Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Brii Biosciences
6271
Brii Biosciences
Health Care
Technology
Biotechnology
Medical
Pharmaceuticals
Management
Brii Biosciences is a biotechnology company that commits to bring innovative medicines to China as a way to improve public health.
Suggest edits
Founded
2018
Raised
$415M
Follow us
Featured on
Also headquartered in San Francisco
Ahelpfulghost
Twitter
Uber
Instagram
TikTok
Lyft
Airbnb
Coinbase
Fitbit
LinkedIn
Companies in the same industry
Trobix Bio
GTx, Inc.
Syntimmune
Karuna Pharmaceuticals
Spruce Biosciences
Remita Health
SutroVax
Atlantic Healthcare plc
eXIthera Pharmaceuticals
Entegrion
Alexa global traffic share
Overview
Funding
2
Investments
1
Add info
Latest funding
$155,000,000
Venture capital (Series C) - 2021
GIC
Lake Bleu Capital
Invesco
$260,000,000
Venture capital - 2018
Sequoia Capital
Boyu Capital
Yunfeng Capital
+3
Team Size
1–10
Employees
I work here
Location
San Francisco
,
United States
Headquarters
Explore San Francisco
$155,000,000
Venture capital (Series C)
AVCJ
Invesco leads $155m round for China's Brii Biosciences
the home of AI info
Brii Biosciences Expands Therapeutic Focus to Include Neurosciences with Addition of John Kraus ...
$260,000,000
Venture capital
AVCJ
Brii Biosciences gets $260m for China expansion
Funding
Xconomy
Brii Biosciences Debuts with a China Pharma Strategy Backed by $260M
Health
Asia
